ephedrine has been researched along with Multiple System Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berding, G; Dengler, R; Knapp, WH; Kolbe, H; Meyer, GJ; Peschel, T; Schrader, CH; van den Hoff, J | 1 |
Brady, CM; Fowler, CJ; Hussain, IF; Mathias, CJ; Swinn, MJ | 1 |
2 trial(s) available for ephedrine and Multiple System Atrophy
Article | Year |
---|---|
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy.
Topics: Carbon Radioisotopes; Diagnosis, Differential; Ephedrine; Feasibility Studies; Heart; Humans; Liver; Metabolic Clearance Rate; Multiple System Atrophy; Myocardium; Organ Specificity; Parkinson Disease; Pilot Projects; Radiopharmaceuticals; Tomography, Emission-Computed; Vagus Nerve | 2003 |
Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension.
Topics: Aged; Blood Pressure; Cross-Over Studies; Diastole; Double-Blind Method; Ephedrine; Erectile Dysfunction; Humans; Hypotension, Orthostatic; Male; Middle Aged; Midodrine; Multiple System Atrophy; Parkinson Disease; Phosphodiesterase Inhibitors; Piperazines; Purines; Quality of Life; Severity of Illness Index; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Systole; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2001 |